Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S2 from Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma
  1. Home
  2. Publications
  3. Figure S2 from Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma

Figure S2 from Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma

Authors:
  • HHHongxiang Hu
    Hongxiang Hu
  • YLYan Li
    Yan Li
  • JPJulia Piasecki
    Julia Piasecki
  • DHDaniela Hosseyni
    Daniela Hosseyni
  • ZYZhicheng Yan
    Zhicheng Yan
  • XLXianghong Liu
    Xianghong Liu
  • KOKen Ogasawara
    Ken Ogasawara
  • SZSimon Zhou
    Simon Zhou
  • YCYiming Cheng
    Yiming Cheng

Open Access
Publisher website
Google Scholar
  • 17 March 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.28606405
Abstract
Orva-cel pharmacokinetic profile by flow cytometry (a) and changes in the composition of CAR-T cells post-infusion (b).
Keywords
  • BIOLOGICAL AGENTS & THERAPIES
  • CELL-BASED THERAPEUTICS
  • COMPUTATIONAL METHODS
  • MATHEMATICAL MODELING
  • HEMATOLOGICAL CANCERS
  • MYELOMAS
  • PHARMACOLOGY
  • PHARMACOKINETICS AND PHARMACODYNAMICS
  • TRANSLATIONAL RESEARCH
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.